VCYT

Veracyte, Inc. - Common Stock (VCYT)

About Veracyte, Inc. - Common Stock (VCYT)

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

Details

Daily high

$27.75

Daily low

$26.79

Price at open

$27.25

52 Week High

$47.32

52 Week Low

$19.73

Market cap

2.1B

Dividend yield

0.00%

Volume

1.1M

Avg. volume

989,584

P/E ratio

64.55

Veracyte, Inc. - Common Stock News